Anti-infection


Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.
Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.
Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.
Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.
Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.
-
BA1091 DjalonensoneSummary: Djalonensone was isolated from the roots of Anthocleistadjalonensis (Loganiaceae). -
BA1092 CyclacillinSummary: Cyclacillin (Wy-4508) is an orally effective aminopenicillin antibiotic. -
BA1093 OzenoxacinSummary: Ozenoxacin is a non-fluoroquinolone antimicrobial agent. -
BA1094 AvarofloxacinSummary: Avarofloxacin (JNJ-Q2) is a broad-spectrum fluoroquinolone antibacterial active molecule used in acute bacterial skin infections as well as acquired pneumonia. -
BA1095 IclaprimSummary: Iclaprim is a new, selective bacterial dihydrofolate inhibitor that inhibits the growth of Staphylococcus aureus. -
BA1096 NifursolSummary: Nifursol is a potent, orally active veterinary antibiotic for the prevention of tissue stomatitis. -
BA1097 CefuroximeSummary: Cefuroxime is an orally active second-generation cephalosporin antibiotic with increased stability against beta-lactamase. -
BA1098 PyrrolnitrinSummary: Pyrrolnitrin is an antibiotic isolated from Pseudomonas syringae. -
BA1100 CefetametSummary: Cefetamet is a cephalosporin antibiotic. -
BA1101 NogalamycinSummary: Nogalamycin is a hydroxynitrosamine cyclamate.

